Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Luttrell

Showing results (171-180 of 194) with videos related to

Pageof 20
Sort By:
Journal of Visualized Experiments : Jove|April 24, 2023
Preclinical Drug Testing in Scalable 3D Engineered Muscle TissuesBonnie J Berry, Shawn M Luttrell, Charles T Moerk, et al.
Nature|March 24, 2016
The conformational signature of β-arrestin2 predicts its trafficking and signalling functionsMi-Hye Lee, Kathryn M Appleton, Erik G Strungs, et al.
Nature|August 31, 1995
Receptor-tyrosine-kinase- and G beta gamma-mediated MAP kinase activation by a common signalling pathwayT van Biesen, B E Hawes, D K Luttrell, et al.
The Journal of Biological Chemistry|February 13, 1999
Serotonin 5-HT1A receptor-mediated Erk activation requires calcium/calmodulin-dependent receptor endocytosisG J Della Rocca, Y V Mukhin, M N Garnovskaya, et al.
The Journal of Biological Chemistry|April 20, 2011
The beta-arrestin pathway-selective type 1A angiotensin receptor (AT1A) agonist [Sar1,Ile4,Ile8]angiotensin II regulates a robust G protein-independent signaling networkRyan T Kendall, Erik G Strungs, Saleh M Rachidi, et al.
Diabetes Care|February 1, 2018
Plasma Connective Tissue Growth Factor (CTGF/CCN2) Levels Predict Myocardial Infarction in the Veterans Affairs Diabetes Trial (VADT) CohortKelly J Hunt, Miran A Jaffa, Sara M Garrett, et al.
The Journal of Biological Chemistry|May 11, 2013
The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimersParker C Wilson, Mi-Hye Lee, Kathryn M Appleton, et al.
The Journal of Biological Chemistry|May 31, 2002
Selective inhibition of heterotrimeric Gs signaling. Targeting the receptor-G protein interface using a peptide minigene encoding the Galpha(s) carboxyl terminusDavid S Feldman, A Musa Zamah, Kristen L Pierce, et al.
The Journal of Biological Chemistry|December 11, 2002
The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activationAkira Tohgo, Eric W Choy, Diane Gesty-Palmer, et al.
Molecular Pharmacology|February 1, 2015
Delineation of a conserved arrestin-biased signaling repertoire in vivoStuart Maudsley, Bronwen Martin, Diane Gesty-Palmer, et al.
Pageof 20

Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
Journal of Visualized Experiments : Jove|April 24, 2023
Preclinical Drug Testing in Scalable 3D Engineered Muscle TissuesBonnie J Berry, Shawn M Luttrell, Charles T Moerk, et al.
Nature|March 24, 2016
The conformational signature of β-arrestin2 predicts its trafficking and signalling functionsMi-Hye Lee, Kathryn M Appleton, Erik G Strungs, et al.
Nature|August 31, 1995
Receptor-tyrosine-kinase- and G beta gamma-mediated MAP kinase activation by a common signalling pathwayT van Biesen, B E Hawes, D K Luttrell, et al.
The Journal of Biological Chemistry|February 13, 1999
Serotonin 5-HT1A receptor-mediated Erk activation requires calcium/calmodulin-dependent receptor endocytosisG J Della Rocca, Y V Mukhin, M N Garnovskaya, et al.
The Journal of Biological Chemistry|April 20, 2011
The beta-arrestin pathway-selective type 1A angiotensin receptor (AT1A) agonist [Sar1,Ile4,Ile8]angiotensin II regulates a robust G protein-independent signaling networkRyan T Kendall, Erik G Strungs, Saleh M Rachidi, et al.
Diabetes Care|February 1, 2018
Plasma Connective Tissue Growth Factor (CTGF/CCN2) Levels Predict Myocardial Infarction in the Veterans Affairs Diabetes Trial (VADT) CohortKelly J Hunt, Miran A Jaffa, Sara M Garrett, et al.
The Journal of Biological Chemistry|May 11, 2013
The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimersParker C Wilson, Mi-Hye Lee, Kathryn M Appleton, et al.
The Journal of Biological Chemistry|May 31, 2002
Selective inhibition of heterotrimeric Gs signaling. Targeting the receptor-G protein interface using a peptide minigene encoding the Galpha(s) carboxyl terminusDavid S Feldman, A Musa Zamah, Kristen L Pierce, et al.
The Journal of Biological Chemistry|December 11, 2002
The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activationAkira Tohgo, Eric W Choy, Diane Gesty-Palmer, et al.
Molecular Pharmacology|February 1, 2015
Delineation of a conserved arrestin-biased signaling repertoire in vivoStuart Maudsley, Bronwen Martin, Diane Gesty-Palmer, et al.
Pageof 20